Skeletal Biology and Late Effects Following Allogeneic Transplantation for Pediatric Hematologic Malignancy: A Ptctc and CIBMTR Multicenter Study

Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), K. Scott Baker, Mark T. Vander Lugt(University of Michigan–Ann Arbor), Michelle Hudspeth(Medical University of South Carolina), Neena Kapoor(St Vincent's Hospital Sydney), Jeffery James Auletta, Kimberly A. Kasow(University of North Carolina at Chapel Hill), Kristen Beebe(Phoenix Children's Hospital), Blachy J Davila, Lyndsay Molinari, Brandon Nuechterlein(University of Colorado Cancer Center), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Eneida R. Nemecek(Oregon Health & Science University), Jeffrey S. Huo, Muna Qayed(Emory University), Emmanuel Katsanis(University of Arizona), W Scott Goebel, Wendy B. London(Dana-Farber Cancer Institute), Christopher C. Dvorak(University of California, San Francisco), Rabi Hanna(Cleveland Clinic), James A. Connelly(Michigan Center for Translational Pathology), Robert H. Lurie, Theodore B. Moore(University of California, Los Angeles), Sonali Chaudhury(Northwestern University), Jignesh Dalal(Rainbow Babies & Children's Hospital), Nahal Lalefar(University of California, San Francisco), Lynnette Anderson, Samantha Kay‐Green, Nan Chen(Qilu Hospital of Shandong University), Shalini Shenoy(Washington University in St. Louis), Paul L. Martin(Duke University), Barbara Bambach(Roswell Park Comprehensive Cancer Center), Benjamin Oshrine(Johns Hopkins All Children's Hospital), Michael A. Pulsipher(Primary Children's Hospital)

Transplantation and Cellular Therapy

February 1, 2023

Cited by 1

|New England Journal of Medicine|2018|5.7k

|Nature Genetics|2013|1.2k

|Transplantation and Cellular Therapy|2020|718

|New England Journal of Medicine|2017|592

|Nature Medicine|2018|577

Related Papers